207 related articles for article (PubMed ID: 12065474)
1. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
Monari C; Kozel TR; Bistoni F; Vecchiarelli A
Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474
[TBL] [Abstract][Full Text] [Related]
2. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.
Vecchiarelli A; Retini C; Casadevall A; Monari C; Pietrella D; Kozel TR
Infect Immun; 1998 Sep; 66(9):4324-30. PubMed ID: 9712784
[TBL] [Abstract][Full Text] [Related]
3. Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.
Sun D; Zhang M; Liu G; Wu H; Zhu X; Zhou H; Shi M
Infect Immun; 2016 Jan; 84(1):216-29. PubMed ID: 26502909
[TBL] [Abstract][Full Text] [Related]
4. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.
Dong ZM; Murphy JW
Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
Retini C; Vecchiarelli A; Monari C; Bistoni F; Kozel TR
Infect Immun; 1998 Feb; 66(2):664-9. PubMed ID: 9453624
[TBL] [Abstract][Full Text] [Related]
6. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
[TBL] [Abstract][Full Text] [Related]
7. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.
Gasque P; Singhrao SK; Neal JW; Götze O; Morgan BP
Am J Pathol; 1997 Jan; 150(1):31-41. PubMed ID: 9006319
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of C5a receptor in mouse microvascular endothelial cells.
Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
[TBL] [Abstract][Full Text] [Related]
9. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA
J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657
[TBL] [Abstract][Full Text] [Related]
10. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells.
Wetsel RA
Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249
[TBL] [Abstract][Full Text] [Related]
11. Analysis of C5a receptor by monoclonal antibody.
Watanabe H; Kuraya M; Kasukawa R; Yanagisawa H; Yanagisawa M; Fujita T
J Immunol Methods; 1995 Sep; 185(1):19-29. PubMed ID: 7665898
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcal polysaccharides bind to CD18 on human neutrophils.
Dong ZM; Murphy JW
Infect Immun; 1997 Feb; 65(2):557-63. PubMed ID: 9009313
[TBL] [Abstract][Full Text] [Related]
13. [The role of C5a in adhesion properties of polymorphonuclear leukocyte to pulmonary vascular endothelial cells in burn patients with acute lung injury].
Lu F; Zhu X; Hu C; Huang Y
Zhonghua Shao Shang Za Zhi; 2002 Dec; 18(6):358-61. PubMed ID: 12641988
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relationships of human C5a and C5aR.
Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA
J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141
[TBL] [Abstract][Full Text] [Related]
16. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion.
Dong ZM; Murphy JW
Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079
[TBL] [Abstract][Full Text] [Related]
17. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
[TBL] [Abstract][Full Text] [Related]
19. [Small increase of CR1 and CR3 by C5a-receptors on polymorphonuclear leukocytes in systemic lupus erythematosus].
Doi T; Takemura S; Onodera H; Ueda M; Deguchi M; Nakahara R; Ichio N; Nakanishi S; Seto N; Yanagida K; Kondo M
Arerugi; 1997 Nov; 46(11):1108-13. PubMed ID: 9436327
[TBL] [Abstract][Full Text] [Related]
20. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A
Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
